SMS Pharmaceuticals posts investor conference call audio

Investor Communications View source PDF Explain this filing

SMSPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.6%Reaction day

₹518.40

prior close

₹514.15

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Pharmaceuticals peers, median of 173sector-0.2%-3.4% vs sector

On the reaction day the stock moved 3.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.4

15m

-1.1

30m

-0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.6pendingpending-0.2-3.4

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The company informed BSE and NSE that an investor and analyst conference call was held on 5 November 2026 to discuss unaudited results for the second quarter and half year ended 30 September 2026. The audio recording is available on its website, but this filing contains no financial details or targets.

Likely market impact

The filing is administrative and provides no new financial information. Investors need to review the call recording for business updates.